Professional Documents
Culture Documents
A Stronger Biofilm: Clinical Abstracts
A Stronger Biofilm: Clinical Abstracts
Ingrid Sevels
Clinical Abstracts
DDSBA
A Stronger Biofilm
Topical Physostigmine
Tbis recent cross-over and randomized study
tested tbe efficacy and appropriate dosage of
pbysostigmine, a tertiary amine tbat enbances
tbe cbolinergic tone of secretory cells, for tbe
management of dry moutb.
Twenty people witb dry moutb and byposalivation received a topical gel containing eitber
pbysostigmine (0.9, 1.8, 3.6, or 7.2mg) or a
placebo. Tbe product was applied to tbe inside
of tbe lips and distributed via tbe tongue. Feeling of dryness, saliva volumes and systemic effects were measured, witb tbe following findings:
Tbe 3.6 and 7.2mg doses of pbysostigmine
produced gastrointestinal side-effects.
At 1.8 mg, pbysostigmine gave two to tbree
bours of relief from tbe subjective feeling of
moutb dryness. No systemic effects were noted
witb tbis dosage.
Tbe response witb pbysostigmine was five
times greater tban witb tbe placebo.
Systemic drug treatments for dry moutb may
cause uncomfortable side-effects. Having a local
agent witb minimal adverse effects is attractive
to botb patient and practitioner.
Eur J Oral Sei 117:209-217, 2009
Clinical Abstracts
Chartered Financial
Consulting Inc.
(ORTHOBVTE)
Whether you are using Orthobyte for
3D Digital iVIodeis, Indirect Bonding, Appiiances,
or aii of the above,
Orthobyte^" is easy to use and cost effective.
3D Digital Models
Indirect Bonding
Yes, seriously.
Nance Button
Hyrax Auxiliary Expander
Call: 905-655-0095 or
Toll-free: 866-682-4829
email: info@strategicedge.net
800-206-4452
19
Copyright of Ontario Dentist is the property of Ontario Dentist and its content may not be copied or emailed to
multiple sites or posted to a listserv without the copyright holder's express written permission. However, users
may print, download, or email articles for individual use.